RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor of RUNX1/ETO tetramerization with anti-leukemic activity; it specifically targets the NHR2 domain of RUNX1/ETO (EC50 = 0.25 μM), restores expression of RUNX1/ETO-downregulated genes, inhibits proliferation of RUNX1/ETO-dependent SKNO-1 cells, and suppresses RUNX1/ETO-associated tumor growth in mouse models.